Correlation Between Monte Rosa and Orchestra BioMed

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Orchestra BioMed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Orchestra BioMed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Orchestra BioMed Holdings, you can compare the effects of market volatilities on Monte Rosa and Orchestra BioMed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Orchestra BioMed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Orchestra BioMed.

Diversification Opportunities for Monte Rosa and Orchestra BioMed

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Monte and Orchestra is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Orchestra BioMed Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orchestra BioMed Holdings and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Orchestra BioMed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orchestra BioMed Holdings has no effect on the direction of Monte Rosa i.e., Monte Rosa and Orchestra BioMed go up and down completely randomly.

Pair Corralation between Monte Rosa and Orchestra BioMed

Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to under-perform the Orchestra BioMed. But the stock apears to be less risky and, when comparing its historical volatility, Monte Rosa Therapeutics is 1.25 times less risky than Orchestra BioMed. The stock trades about -0.09 of its potential returns per unit of risk. The Orchestra BioMed Holdings is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  587.00  in Orchestra BioMed Holdings on August 28, 2024 and sell it today you would lose (30.00) from holding Orchestra BioMed Holdings or give up 5.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Monte Rosa Therapeutics  vs.  Orchestra BioMed Holdings

 Performance 
       Timeline  
Monte Rosa Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Monte Rosa Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Monte Rosa exhibited solid returns over the last few months and may actually be approaching a breakup point.
Orchestra BioMed Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Orchestra BioMed Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's forward indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Monte Rosa and Orchestra BioMed Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monte Rosa and Orchestra BioMed

The main advantage of trading using opposite Monte Rosa and Orchestra BioMed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Orchestra BioMed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orchestra BioMed will offset losses from the drop in Orchestra BioMed's long position.
The idea behind Monte Rosa Therapeutics and Orchestra BioMed Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon